Pancreatic Cancer Research

ResearcherSelçuk UniversityActive in the last 2 years

Esma Menevşe

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5477-5667; OpenAlex author ID A5079829342. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

  1. Juglone-ascorbate treatment enhances reactive oxygen species mediated mitochondrial apoptosis in pancreatic cancer. Last author DOI 10.1007/s11033-024-09254-6↗
  2. Investigation of the effects of the toll-like receptor 4 pathway on immune checkpoint vista in pancreatic cancer. Co-author DOI 10.1007/s10637-021-01209-z↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ebru Güçlü · 1 shared paper, 2024 · strength 0.28
  2. Hilal Arıkoğlu · 1 shared paper, 2024 · strength 0.28
  3. Dudu Erkoç Kaya · 1 shared paper, 2024 · strength 0.28
  4. Duygu Dursunoğlu · 1 shared paper, 2024 · strength 0.28
  5. Tuğçe Duran · 1 shared paper, 2022 · strength 0.20
  6. Kübra Sena Baş Topcu · 1 shared paper, 2022 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.